Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Shareholders??? Equity (Capital Deficiency)

v3.23.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Shareholders’ Equity (Capital Deficiency) - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Common Stock
Non-voting Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2020 $ 5,585 [1] $ 2,771 $ (17,169) $ (14,398)
Balance (in Shares) at Dec. 31, 2020 7,731,083 2,047,641 1,783,773      
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2021:            
Exercise of options into common stock [1] [1]
Exercise of options into common stock (in Shares)   2,763        
Share based compensation 53 53
Net comprehensive loss for the year (5,251) (5,251)
Balance at Dec. 31, 2021 $ 5,585 [1] [1] 2,824 (22,420) (19,596)
Balance (in Shares) at Dec. 31, 2021 7,731,083 2,050,404 1,783,773      
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2021:            
Exercise of options into common stock [1] 5 5
Exercise of options into common stock (in Shares)   77,749        
Conversion of convertible preferred stock to common stock upon initial public offering $ (5,585) $ 1 5,584 5,585
Conversion of convertible preferred stock to common stock upon initial public offering (in Shares) (7,731,083) 7,731,083        
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs [1] 14,675 14,675
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares)   4,212,500        
Conversion of convertible loan to common stock upon initial public offering [1] 6,553 6,553
Conversion of convertible loan to common stock upon initial public offering (in Shares)   1,638,161        
Conversion of convertible note to common stock upon initial public offering [1] 3,600 3,600
Conversion of convertible note to common stock upon initial public offering (in Shares)   900,096        
Conversion of warrants to common stock upon initial public offering [1] 3,190 3,190
Conversion of warrants to common stock upon initial public offering (in Shares)   797,567        
Redemption of non-voting common stock upon initial public offering [1] [1]
Redemption of non-voting common stock upon initial public offering (in Shares)     (1,783,773)      
Repurchase of common stock [1] 15 15
Repurchase of common stock (in Shares)   (27,699)        
Share based compensation 220 220
Net comprehensive loss for the year (10,982) (10,982)
Balance at Dec. 31, 2022 $ 1 $ 36,666 $ (33,402) $ 3,265
Balance (in Shares) at Dec. 31, 2022   17,379,861        
[1] Represents an amount less than $1 thousands.